Robert S. Warren
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 40
- Colorectal Cancer Treatments and Studies 15
- Pancreatic and Hepatic Oncology Research 8
-
- Angiogenesis and VEGF in Cancer 10
- Co-authors
- David B. Donner (27 shared papers)Mary Matli (13 shared papers)Napoleone Ferrara (1 shared paper)Hui Yuan (1 shared paper)Nancy A. Gillett (1 shared paper)Donna Niedzwiecki (14 shared papers)Ying Lü (2 shared papers)David H. Kirn (3 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Journal of Biological Chemistry (8 papers)Journal of Surgical Research (5 papers)Surgical Oncology Clinics of North America (4 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Robert S. Warren
121 papers receiving 8.5k citations
Robert S. Warren's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 3.1k
- Hepatology 788
- Cancer Research 1.2k
- Pathology and Forensic Medicine 1.0k
- Molecular Biology 3.2k
Countries citing papers authored by Robert S. Warren
This map shows the geographic impact of Robert S. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Warren more than expected).
Fields of papers citing papers by Robert S. Warren
This network shows the impact of papers produced by Robert S. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Warren. The network helps show where Robert S. Warren may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Warren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. Hit paper breakdown → | 1995 | 574 |
| 2 | 2001 | 456 | |
| 3 | 2002 | 415 | |
| 4 | 1995 | 395 | |
| 5 | 2006 | 308 | |
| 6 | 2009 | 280 | |
| 7 | 2017 | 265 | |
| 8 | 2000 | 259 | |
| 9 | 2000 | 251 | |
| 10 | Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. | 1997 | 245 |
| 11 | beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. | 2003 | 245 |
| 12 | 1988 | 240 | |
| 13 | 2001 | 221 | |
| 14 | 1996 | 218 | |
| 15 | 2013 | 210 | |
| 16 | 2003 | 192 | |
| 17 | 1987 | 190 | |
| 18 | 2002 | 189 | |
| 19 | 1987 | 184 | |
| 20 | 2019 | 152 |
About Robert S. Warren
Robert S. Warren is a scholar working on Oncology, Molecular Biology, Surgery, Hepatology and Epidemiology, having authored 123 papers that have together received 8.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Neuroendocrine Tumor Research Advances (11 papers), Angiogenesis and VEGF in Cancer (10 papers), Genetic factors in colorectal cancer (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Oncology (3.1k citations), Hepatology (788 citations), Cancer Research (1.2k citations), Pathology and Forensic Medicine (1.0k citations) and Molecular Biology (3.2k citations). Robert S. Warren has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include David B. Donner, Mary Matli, Napoleone Ferrara, Hui Yuan, Nancy A. Gillett, Donna Niedzwiecki, Ying Lü, David H. Kirn, Alan P. Venook and Murray F. Brennan. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, Journal of Surgical Research, Surgical Oncology Clinics of North America and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.